Although misfolded proteins are ubiquitinated and cleared by the proteasome, they can accumulate in synapses in aged neurons to promote synaptic dysfunction in a variety of neurodegenerative diseases, including Huntington's disease (HD), which is caused by polyglutamine expansion in huntingtin. The mechanism behind this aging-related phenomenon is unknown and has been difficult to investigate using animals with short life spans. With brain tissues from longer-lived rhesus monkeys of different ages, we found that aging reduces ubiquitin-proteasomal activity and also increases the level of ubiquitin-conjugating enzyme UBE2N (Ubc13) in synaptosomes. Synaptosomal fractions from aged monkey brain increase in vitro ubiquitinated huntingtin, whereas depletion of UBE2N markedly reduces this increase.
INTRODUCTION
Protein misfolding causes a variety of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). All these diseases share several common pathological features, including the age-dependent accumulation of misfolded proteins in affected brain regions. In HD, the disease protein, huntingtin (htt), carries an expanded polyglutamine (polyQ, >37Q) domain that causes htt to accumulate in the nucleus, as well as in neuronal processes and terminals (1) (2) (3) . The accumulation of mutant htt in synapses is found to alter synaptic transmitter release in HD mouse models (4) (5) (6) (7) . In addition, targeting mutant htt to the presynaptic terminal in transgenic mice also leads to neurological symptoms and early death (8) , and reducing synaptic mutant htt levels alleviates neurological symptoms (7), indicating a critical role for mutant Htt in synapses in HD pathology. Furthermore, the accumulation of misfolded proteins in synapses and synaptic dysfunction are commonly seen in a variety of neurodegenerative diseases, such as Alzheimer's and Parkinson's, at early disease stages (9) (10) (11) (12) . All these findings underscore our need to understand how misfolded proteins accumulate in the synapses if we are to unravel the pathogenesis of neurodegenerative diseases.
The age-dependent accumulation of misfolded proteins is thought to be due to an impaired cellular capacity to clear these misfolded proteins (7, (13) (14) (15) (16) (17) . Two major routes for removing misfolded proteins are the ubiquitin-proteasome system (UPS) and autophagy (14, (18) (19) (20) (21) . To remove misfolded proteins via the UPS, first the proteins need to be ubiquitinated, and then by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from 4 targeted to the proteasomes for degradation. This process involves the concerted action of three enzymes: ubiquitin-activating (E1), ubiquitin-conjugating (E2), and a number of ubiquitin-ligating (E3) enzymes (22), which confer substrate specificity by facilitating the interaction between a particular substrate and an E2 (23). UPS activity is found to decline with age in different tissue types (24-28), and also in different subcellular regions (7) . Since misfolded proteins selectively accumulate in synapses, there must be other determinants that contribute to this selective accumulation. Knowing the mechanism for this selectivity would help us understand the pathogenesis of age-dependent neurodegenerative diseases.
Our current understanding of disease pathogenesis has been based largely on studies of small animal models, especially mouse models expressing misfolded proteins. Although these mouse models have yielded valuable information for important pathological and mechanistic events in neurodegenerative diseases, species differences and short life spans have also limited the usefulness of small animal models to recapitulate some important pathological changes seen in patient brains. For example, most transgenic mouse models do not mimic the striking neurodegenerative phenomena in different neurodegenerative diseases, such as AD, PD, and HD (29, 30) . Transgenic models of large animals that are closer to humans appear to be more sensitive to misfolded proteins and show more robust pathological changes than transgenic mouse models. For example, transgenic HD monkeys die earlier and display more severe axonal degeneration than mouse models expressing the same short mutant htt fragment (31, 32) . The differences seen in primate and rodent models indicate clearly that species differences can determine the nature of neuropathology, underscoring the importance of studying pathogenesis in non-human primates (33) . In the current study, we used rhesus monkey brain tissues to investigate how mutant htt accumulates in the brain. Because synaptic dysfunction is the common pathological feature in many different neurodegenerative diseases, we focused on synaptosomal fractions of monkey brains at different ages. Our studies revealed that the level of ubiquitin-conjugating enzyme UBE2N (Ubc13) in synaptosomes increases with aging and that its expression levels influence the accumulation of mutant htt in neuronal cells. Our findings have uncovered a new target for the selective accumulation of misfolded proteins in neuronal terminals.
RESULTS

Age-dependent Decrease in UPS Activity in Monkey Brain
The fact that misfolded proteins accumulate in the aged brain led us to examine ubiquitin-proteasome system activity in the brain tissues of monkeys at different ages. We deeply anesthetized rhesus monkeys at 2, 8, and 22 years of age, and then immediately isolated tissues from different brain regions and peripheral organs. Such freshly isolated tissues allowed us to biochemically analyze primate brain and peripheral tissues without the influence of postmortem-related protein degradation. We compared chymotrypsin-like and postglutamyl-like activities in the monkey brain cortex, striatum, liver, and muscle tissues. These proteasomal activities are higher in liver than in brain and muscle tissues ( Figure 1A, B) . Importantly, proteasomal activities in the brain (striatum and cortex) tissues significantly decline with age, but are not significantly altered in liver and muscle tissues ( Figure 1A, B) .
The decreased proteasomal activity we saw could lead to the accumulation of ubiquitinated proteins, so we examined the ubiquitination of proteins in these tissues via western blotting with 6 anti-ubiquitin. The results indeed showed that some ubiquitinated proteins are more abundant in the brain cortex and striatum than in the liver and muscle. Importantly, aging apparently increases the levels of ubiquitinated proteins ( Figure 1C, D) . The differential accumulation of ubiquitinated proteins in monkey tissues is similar to what we recently found in mouse tissues (34) . Thus, using freshly isolated monkey tissues, we found that proteasome activity in primate brain tissues is more vulnerable to aging than in the peripheral tissues.
Increased UBE2N Expression in Synaptosomes of Aged Monkey Brain Tissues
Several neurodegenerative diseases, as among them AD, PD, and HD, are characterized by the accumulation of misfolded proteins in synapses and synaptic dysfunction (7, (35) (36) (37) . To investigate whether aging alters the levels of proteins that are involved in protein degradation in synapses, we used monkey brain striatum to isolate the subcellular fraction P2 that is enriched in synaptosomes ( Figure S1 ). Isolated synaptosomes from monkeys at 3 different ages were subjected to quantitative proteomics analysis in which samples were differentially labeled with four-plex isobaric tag for relative and absolute quantitation (iTRAQ) reagents (114-117), and then analyzed by liquid chromatography coupled with tandem mass spectrometry Figure S3 ). More mitochondrial proteins are upregulated from 2 to 8 years than from 8 years to 22 years. Interestingly, there is concomitant down-and upregulation of several proteins for "Protein synthesis, folding, and degradation" from 2 to 8 years, whereas greater downregulation is seen from 8 to 22 years. This result is consistent with the age-dependent decline in clearance of misfolded proteins in neurodegenerative diseases. Of these proteins, UBE2N was increased in adult monkey brains. The protein-protein interactions network determined by STRING analysis also revealed that UBE2N is associated with the proteasome 26S subunit ATPase and non-ATPase in the network ( Figure 2D ). Taken together, our data show an age-dependent dysregulation of distinct synaptic proteins in monkey brains.
Since UBE2N is important for targeting misfolded proteins for degradation, we focused on the analysis of UBE2N and its effect on the accumulation of misfolded proteins. To verify the age-dependent altered level of UBE2N seen in the iTRAQ assay, we performed western blotting of monkey brain samples. UBE2N was increased in synaptosomes from the striatum and cortex of 8-and 22-year-old monkeys compared with 2-year-old monkey ( Figure 3A, B) . However, UBE2K, another E2 conjugating enzyme, was unchanged, suggesting a selective increase in UBE2N in adult monkey brains. There is a slight decrease in UBE2K and UBE2N in 22-year-old monkey brain compared with 8-year-old monkey brain, which may be due to a loss of synapses in very old animals. Furthermore, we examined P2 fractions from liver and muscle, which were isolated using similar conditions for isolating synaptosomes, and found that UBE2N was not by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from 8 increased in these peripheral tissues with age ( Figure 3C ). All these results support the selective upregulation of UBE2N in synaptosomes in monkey brains with age and the relevance of this change to selective neuropathology in age-dependent neurodegenerative diseases. Since the age of 8 years in monkey is equivalent to adult humans, the increased UBE2N at 8 years of age implies that synaptic UBE2N is upregulated in adult primate monkey brains.
Synaptosomal Fractions from Aged Monkey Brains Promote Mutant htt Accumulation
We thought it was important to explore whether misfolded proteins are more likely to accumulate in the synaptosome from aged monkeys. We used mutant htt for this investigation, as htt misfolding is mediated by polyQ expansion in its N-terminal region. Because of the early death of previously established transgenic HD monkeys (32), we did not have monkey brain tissues that express mutant htt. We therefore used an in vitro assay, which we developed recently (34) , to examine the effect of synaptosomes from monkeys at different ages on htt accumulation. In this assay, transfected exon1-97Q htt from HEK293 cells was precipitated by anti-htt ( Figure S4A ).
The precipitated htt was then incubated with synaptosomal fractions isolated from the cortex of monkeys at 2, 8, and 22 years of age ( Figure 4A ). We assumed that the in vitro incubation of synaptosomes from monkeys at different ages under the same conditions would reveal age-related factors that may alter htt stability. Indeed, we saw that the synaptosomal fractions from older monkeys caused more exon1-97Q htt to accumulate in the incubation ( Figure 4B , left panel). To verify that this assay does reflect the ubiquitin-proteasomal degradation event, we added the proteasome inhibitor MG132 to the incubation and saw that inhibiting the UPS eliminated the age-dependent difference in htt accumulation ( Figure 4B , right panel), which is consistent with the age-dependent decrease in UPS activity in aged monkey brain ( Figure 1 ).
Next, we were interested to know whether there is age-related ubiquitination in monkey brain synaptosomes, so we examined htt ubiquitination after incubating htt with synaptosomal fractions from monkeys of different ages. As expected, synaptosomal fractions from older monkeys caused more intensive ubiquitination of htt, suggesting there are increased amounts of ubiquitinated htt in the aged synaptosomes ( Figure 4C ). To verify that this increased ubiquitination is related to the presence of UBE2N, we used anti-UBE2N to deplete UBE2N in synaptosomal fractions via immunoprecipitation. This depletion markedly reduced the ubiquitination of mutant htt ( Figure 4C ), suggesting that the age-dependent increase in htt ubiquitination requires UBE2N.
We already know that UBE2N mediates K63 ubiquitination of proteins (38) (39) (40) , and our recent study shows that N-terminal htt is differentially ubiquitinated by ubiquitin with mutations at different lysine residues (41) . Using the same approach to immunoprecipitate N-terminal htt that was transfected with ubiquitin or its mutant forms (K48, K48R, K63, K63R), we indeed confirmed that exon1-97Q htt is ubiquitinated via K63 to a greater extent than via K48 ( Figure S4B ). Importantly, when UBE2N was coexpressed with exon1-97Q htt, it dramatically promoted K63 ubiquitination of htt compared with the absence of transfected UBE2N ( Figure 4D ). Taken together, these results suggest that increased levels of UBE2N can promote the accumulation and aggregation of mutant htt.
Altering the Accumulation of Mutant htt by UBE2N Expression
The age-dependent accumulation of misfolded proteins is determined by multiple factors, Because of its associated polyQ expansion that causes protein misfolding, HD makes an ideal model to investigate how aging can cause the accumulation of misfolded proteins. Clearance of misfolded proteins by the ubiquitin-proteasome system involves sequential reactions mediated by multiple proteins. Ubiquitin is covalently attached to substrate lysines in a three-enzyme cascade catalyzed by E1, E2, and E3 enzymes (47) . In this cascade, E1 activating enzymes initiate ubiquitination, E2 enzymes conjugate ubiquitin to substrates, and E3 ligases specify targeting the right E2-conjugated substrates to the proteasome for degradation. Using monkey brain tissues with a focus on the accumulation of mutant htt, our findings suggest that an age-dependent increase in the UBE2-conjugated enzyme UBE2N plays an important role in the accumulation of misfolded proteins in synaptosomes.
Evidence that supports an important role for UBE2N in the age-dependent accumulation of misfolded proteins comes from the following findings in our studies. Proteomics and western blotting revealed that the level of UBE2N is increased in synaptosomes from rhesus monkeys at the age of 8 years, which is equivalent to the age of 28 years in humans; this is sustained until 22 years of age, which corresponds to the age of 77-80 years in humans. Since we know aging can ubiquitination can also lead to the accumulation of ubiquitinated proteins when the clearance of these proteins by the UPS is impaired (14, 41, 56) . Indeed, in aged monkey brains, we also saw a decline in UPS activity in the same manner as rodent brains (31) . K48 ubiquitination is generally believed to lead to proteasomal degradation, whereas K63 ubiquitination regulates protein translocalization, function, and interactions. However, many studies have also shown that some proteins can be degraded by the proteasomes via K63 ubiquitination (57-60). It is possible that impaired UPS activity in the synapses also contributes to the accumulation of K63-ubiquitinated mutant htt in nerve terminals if K63-ubiquitinated htt is degraded by the proteasome. Since we did 14 not find a global increase of UBE2N in the brain lysates, the age-dependent increase of UBE2N in the synaptosomal fraction in aged monkey brains suggests that this increase is specific for the accumulation of misfolded proteins in the nerve terminals.
Because UBE2N can conjugate ubiquitin to various proteins, we would expect increased UBE2N to occur under different pathological conditions. Indeed, UBE2N has more than threefold upregulation in metastases in the lungs (61) and is upregulated in the striatum and hippocampus in methamphetamine-induced neurotoxicity in different regions of rat brain (62) . Moreover, proteasome inhibition promotes Parkin-UBE2N interaction and lysine 63-linked ubiquitination (39) , and UBE2N upregulation is thought to contribute to parkin-mediated mitophagy, as knockdown prevented specifically K63-linked ubiquitination at mitochondrial sites (63) . Also, alpha-synuclein knockdown exacerbates glutamate neurotoxicity and stimulates the expression of UBE2N (64).
While E3 ligases are involved in substrate selection, E2 conjugating enzymes are the main determinants for selection of lysine to construct ubiquitin chains, which thereby directly control the cellular fate of substrates. In humans, there are 35 active E2 enzymes versus 16 to 35 E2 family members in other species. These differences also underscore the importance of studying the E2 enzymes in primates if we are to understand how misfolded proteins accumulate or are degraded in primate brains. Using the monkey brain tissue and iTRAQ/proteomics approaches, we identified UBE2N as an important target in the accumulation of misfolded proteins in the synaptosomes of adult brains. A key implication of this age-dependent increase of UBE2N is that it may also underlie the age-dependent accumulation of misfolded proteins in the synapses in other neurodegenerative diseases. By investigating the age-related accumulation of aggregated htt, our findings offer a new mechanistic insight into the age-dependent accumulation of misfolded proteins in the synapse, as well as an additional therapeutic target for HD treatment. 
MATERIALS AND METHODS
Animals
Quantitative Protein Identification Using LC-MS
The brain striatum of monkeys at 2, 8, and 22 years of age (n=3 each age) were used to isolate synaptosomal fractions. The fractions of the same amounts of proteins from the monkeys at the same age were pooled. We treated the fractions (100 μg protein for each sample) with 10 mM DTT at 37°C for 4 h, and then 55 mM iodoacetamide at room analysis was performed using the software PSPEP integrated with the ProteinPilot.
Proteasome Activity Assay
To determine proteasome activity, all the tissue samples were adjusted to 0.5 mg/ml total protein by dilution with homogenization buffer. All assays were done in triplicate.
Chymotrypsin-like activity of 20S-beta-5 was determined using the substrate 
In Vitro Ubiquitination Assay
HEK293 cells stably expressing transfected full-length htt were grown to confluence in a 10-cm plate. Cells were washed in the plate, then lysed in cold assay buffer (25 mM Tris-HCl, pH 7.6, 10 mM MgCl 2 , 100 ug/ml purified rabbit creatine kinase, 50 mM phosphocreatine, 1 mM ATP). Wild-type monkey cortex tissues of different ages were rapidly collected and homogenized at 1 g/1 ml in cold assay buffer using 20 strokes of a glass dounce hand homogenizer. Both cell lysates and tissues were centrifuged 500xg at 4°C for 5 min to pellet unbroken tissues and membranes. The supernatant was collected and stored on ice while protein concentrations were determined using a BCA Protein Assay Kit (Thermo Scientific). Both tissue and cell lysates were prepared at 170 µg protein/500 µl assay buffer, and the appropriate number of 200 µl aliquots were prepared.
The 
Fractionation of Brain Tissues
The brains of monkeys at 2-, 8-or 22-years of age were dissected to isolate the cortex, at -80℃. The same amounts of proteins of each fraction were resolved in Tris-glycine gel (Invitrogen) and subjected to western blotting.
Stereotaxic Injection
Adult WT and HD 140Q KI mice at the age of 11 months (n=2 each group) were anesthetized by i.p. injection of 2.5% Avertin, and their heads were placed in a Kopf stereotaxic frame (Model 1900) equipped with a digital manipulator, a UMP3-1 Ultra pump, a 10-μl Hamilton microsyringe (Hamilton Co., Reno, NV, USA), and a 33G needle was inserted through a 1-mm drilled hole on the scalp. Injections were made at the following stereotaxic coordinates: 0.5 mm anterior to bregma; 2.0 mm lateral to the midline (left or right side); 3.3 mm ventral to the dura, with bregma set at zero. The microinjections were carried out at a rate of 0.20 μl/min. The microsyringe was left in place for an additional 10 min before and after each injection. A total of 2.5X10 10 vg virus (AAV-UBE2N or AAV-GFP as control virus) was stereotaxically injected into the right striatum of mice. N212-120Q-htt lentivirus (described before) (34) was injected bilaterally. Two weeks after injections, animals were killed, and the striatum was isolated and subjected to immunofluorescent staining to examine the expression of GFP or hUBE2N. For each animal, multiple brain sections (>6) were used for quantification of htt aggregates per image (40X).
UBE2N Knockdown
Statistical Analyses
Statistical significance was assessed using the 2-tailed Student's t-test whenever two groups were compared. Three monkeys at each age group provided tissues for western blotting, and three or more western blot experiments were often repeated for each money tissue. When analyzing multiple groups, we used one-way ANOVA to determine statistical significance. Data Aging reduces the activity of UPS and increases the level of UBE2N in synaptosomes, resulting in the accumulation of ubiquitinated htt in synapses and associated neuronal toxicity.
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